BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29891438)

  • 41. Emerging roles for A20 in islet biology and pathology.
    Zammit NW; Grey ST
    Adv Exp Med Biol; 2014; 809():141-62. PubMed ID: 25302370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes?
    Johnson KH; O'Brien TD; Westermark P
    Diabetes; 1991 Mar; 40(3):310-4. PubMed ID: 1999270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose and ATP levels in pancreatic islet tissue of normal and diabetic rats.
    Matschinsky FM; Pagliara AS; Stillings SN; Hover BA
    J Clin Invest; 1976 Nov; 58(5):1193-200. PubMed ID: 136453
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.
    Lawlor N; George J; Bolisetty M; Kursawe R; Sun L; Sivakamasundari V; Kycia I; Robson P; Stitzel ML
    Genome Res; 2017 Feb; 27(2):208-222. PubMed ID: 27864352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TLR4 is required for the obesity-induced pancreatic beta cell dysfunction.
    Li J; Chen L; Zhang Y; Zhang WJ; Xu W; Qin Y; Xu J; Zou D
    Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1030-8. PubMed ID: 23985305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interrogating islets in health and disease with single-cell technologies.
    Carrano AC; Mulas F; Zeng C; Sander M
    Mol Metab; 2017 Sep; 6(9):991-1001. PubMed ID: 28951823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CART is a novel islet regulatory peptide.
    Wierup N; Sundler F
    Peptides; 2006 Aug; 27(8):2031-6. PubMed ID: 16842887
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucocorticoid receptor expression is altered in pancreatic beta cells of the non-obese diabetic mouse during postnatal development.
    Thompson A; Arany EJ; Hill DJ; Yang K
    Metabolism; 2002 Jun; 51(6):765-8. PubMed ID: 12037732
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cycad toxin-induced damage of rodent and human pancreatic beta-cells.
    Eizirik DL; Kisby GE
    Biochem Pharmacol; 1995 Jul; 50(3):355-65. PubMed ID: 7646537
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Role of the Islet Niche on Beta Cell Structure and Function.
    Lammert E; Thorn P
    J Mol Biol; 2020 Mar; 432(5):1407-1418. PubMed ID: 31711959
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fas and Fas ligand immunolocalization in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
    Redd S; Ginn S; Ross JM
    Histochem J; 2002; 34(1-2):1-12. PubMed ID: 12365794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
    Johnson KH; O'Brien TD; Betsholtz C; Westermark P
    Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolomics applied to the pancreatic islet.
    Gooding JR; Jensen MV; Newgard CB
    Arch Biochem Biophys; 2016 Jan; 589():120-30. PubMed ID: 26116790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Entrapment of dispersed pancreatic islet cells in CultiSpher-S macroporous gelatin microcarriers: Preparation, in vitro characterization, and microencapsulation.
    Del Guerra S; Bracci C; Nilsson K; Belcourt A; Kessler L; Lupi R; Marselli L; De Vos P; Marchetti P
    Biotechnol Bioeng; 2001 Dec; 75(6):741-4. PubMed ID: 11745153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinctions between islet neogenesis and β-cell replication: implications for reversal of Type 1 and 2 diabetes.
    Levetan C
    J Diabetes; 2010 Jun; 2(2):76-84. PubMed ID: 20923488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies.
    Meece J
    Curr Med Res Opin; 2007 Apr; 23(4):933-44. PubMed ID: 17407650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genomics of Islet (Dys)function and Type 2 Diabetes.
    Lawlor N; Khetan S; Ucar D; Stitzel ML
    Trends Genet; 2017 Apr; 33(4):244-255. PubMed ID: 28245910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Encapsulation of pancreatic islets for transplantation in diabetes: the untouchable islets.
    de Vos P; Marchetti P
    Trends Mol Med; 2002 Aug; 8(8):363-6. PubMed ID: 12127717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pancreatic beta-cell growth and diabetes mellitus.
    Swenne I
    Diabetologia; 1992 Mar; 35(3):193-201. PubMed ID: 1563578
    [No Abstract]   [Full Text] [Related]  

  • 60. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
    Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
    Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.